腸内微生物由来代謝物トリメチルアミン-N-オキシド（TMAO）と心血管リスクバイオマーカー：システマティックレビューおよび用量反応メタアナリシス

Schiattarellaら（Tue,）はその他の研究を報告。トリメチルアミン-N-オキシド（TMAO）血漿濃度は、心血管リスクおよび死亡率の増加と正の用量依存的関連を示す。

www.synapsesocial.com/papers/69f0cfebb606b7e8fdeb2f44 — DOI: https://doi.org/10.1093/eurheartj/ehx342

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Intestinal Microbiota‐Generated Metabolite Trimethylamine‐ <i>N‐</i> Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort· 2016 · 260 citations
2. Mechanisms linking obesity with cardiovascular disease· 2006 · 2,800 citations
3. Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis